Simplex Trading, LLC Denali Therapeutics Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 3,475 shares of DNLI stock, worth $80,967. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,475

Previous 4,934 29.57%

Holding current value

$80,967

Previous $114,000 11.4%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$20.96 - $31.05 $30,580 - $45,301	-1,459 Reduced 29.57%	3,475 $101,000
Q2 2024 Jul 25, 2024	BUY	$14.96 - $23.22 $89 - $139	6 Added 0.12%	4,934 $114,000
Q1 2024 Apr 25, 2024	BUY	$15.83 - $23.35 $78,010 - $115,068	4,928 New	4,928 $101,000
Q1 2023 Apr 27, 2023	BUY	$21.91 - $32.67 $107,600 - $160,442	4,911 Added 355.35%	6,293 $144,000
Q4 2022 Feb 02, 2023	SELL	$26.28 - $33.92 $54,347 - $70,146	-2,068 Reduced 59.94%	1,382 $38,000
Q3 2022 Nov 04, 2022	BUY	$25.97 - $38.53 $89,596 - $132,928	3,450 New	3,450 $105,000
Q1 2022 May 02, 2022	SELL	$29.0 - $47.27 $271,904 - $443,203	-9,376 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$42.59 - $55.02 $399,323 - $515,867	9,376 New	9,376 $418,000
Q2 2021 Aug 12, 2021	SELL	$50.3 - $78.44 $22,584 - $35,219	-449 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$53.8 - $81.53 $24,156 - $36,606	449 New	449 $25,000
Q3 2020 Oct 14, 2020	SELL	$23.13 - $38.84 $1,873 - $3,146	-81 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$16.01 - $28.82 $40,377 - $72,684	-2,522 Reduced 96.89%	81 $1,000
Q1 2020 Apr 29, 2020	SELL	$14.2 - $27.98 $64,070 - $126,245	-4,512 Reduced 63.42%	2,603 $45,000
Q4 2019 Feb 05, 2020	SELL	$14.4 - $19.99 $10,080 - $13,992	-700 Reduced 8.96%	7,115 $123,000
Q3 2019 Oct 15, 2019	BUY	$15.32 - $21.92 $117,887 - $168,674	7,695 Added 6412.5%	7,815 $119,000
Q2 2019 Jul 26, 2019	SELL	$18.5 - $28.14 $7,825 - $11,903	-423 Reduced 77.9%	120 $2,000
Q1 2019 Apr 18, 2019	BUY	$17.99 - $24.65 $9,768 - $13,384	543 New	543 $0
Q4 2018 Jan 16, 2019	SELL	$13.88 - $21.75 $15,462 - $24,229	-1,114 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$12.46 - $21.74 $13,880 - $24,218	1,114 New	1,114 $24,000

Others Institutions Holding DNLI

# of Institutions

226

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Denali Therapeutics Inc. Transaction History